Advertisement
Canadian Journal of Cardiology
Clinical Research| Volume 39, ISSUE 3, P321-330, March 2023

Evolution in Trends of Primary Lower-Extremity Amputations Associated With Diabetes or Peripheral Artery Disease From 2006 to 2019

Published:November 26, 2022DOI:https://doi.org/10.1016/j.cjca.2022.11.010

      Abstract

      Background

      Given the importance in prevention of lower extremity amputations (LEAs) associated with diabetes or peripheral artery disease (PAD), we sought to document the trends of primary LEA in Québec, Canada, from years 2006 to 2019.

      Methods

      Using the Québec Integrated Chronic Disease Surveillance System, we calculated crude and age-standardized annual incidence rates of primary LEA associated with diabetes and PAD among adults ≥ 40 years (99% confidence intervals [CI]), and all-cause 1-year mortality proportion trends following a primary LEA (95% CI), stratified by minor or major as the highest level of LEA during the same hospital stay and age groups. Trends were assessed using multivariate regression models.

      Results

      In 2019, the crude rate of primary LEA was 116.0 per 100,000 (n = 825) with 93.7 and 21.9 per 100,000 of minor (n = 665) and major (n = 160) LEA, respectively. A tendency of decrease by 8% (–15.0 to 0.4%) of age-standardized incidence of primary LEA was observed between 2006 and 2019, while the absolute number of primary LEA increased from 610 to 825 cases. Minor LEA increased by 14.2% (3.7 to 25.9%) and major LEA decreased by 49.5% (–57.1 to –40.5%). Incidence trends remained stable among the 40 to 64 years, and declined by 14.6% and 20.1% for the 65 to 79 and ≥ 80 years of age groups, respectively. Major LEA decreased in all age groups, whereas minor LEA increased by 26.2% among the patients 40 to 64 years of age only. Age-standardized 1-year mortality decreased by 35.1% (95% CI, –43.4 to –25.7%) between 2006 and 2019, with a crude 1-year mortality of 11.3% in 2019.

      Conclusions

      The reduction of major LEA and 1-year mortality are encouraging, although increased minor LEA, especially in younger age groups, emphasizes the importance to improve preventive care further.

      Résumé

      Contexte

      Étant donné l’importance de prévenir les amputations d’un membre inférieur associées au diabète et à la maladie artérielle périphérique (MAP), nous avons voulu documenter l'incidence des amputations primaires d’un membre inférieur au Québec (Canada) entre 2006 et 2019.

      Méthodologie

      À l’aide du Système intégré de surveillance des ma- ladies chroniques du Québec, nous avons calculé le taux d’incidence annuel brut et le taux d’incidence annuel standardisé selon l’âge des amputations primaires d’un membre inférieur associées au diabète et à la MAP chez les adultes de 40 ans ou plus (intervalles de confiance [IC] à 99 %), et les proportions de mortalité de toute cause à 1 an après une amputation primaire d’un membre inférieur (IC à 95 %). Nous avons ensuite stratifié ces données selon le niveau de l’amputation lors d’un même séjour à l’hôpital (mineure ou majeure), et par groupes d’âge. Les tendances ont été évaluées à l’aide de modèles de régression multivariés.

      Résultats

      En 2019, le taux brut d’amputations primaires d’un membre inférieur était de 116,0 pour 100 000 cas (n = 825), avec 93,7 amputations mineures (n = 665) et 21,9 amputations majeures (n = 160) pour 100 000 cas. Une tendance à la baisse de 8 % (-15,0 à 0,4 %) a été notée dans l’incidence standardisée selon l’âge des amputations primaires entre 2006 et 2019, avec une augmentation du nombre d'amputations de 610 à 825 cas. Les amputations mineures étaient en hausse de 14,2 % (3,7 à 25,9 %) et les amputations majeures, en baisse de 49,5 % (-57,1 à -40,5 %). La tendance dans le taux d’incidence est demeurée stable chez les 40 à 64 ans, et a chuté de 14,6 % et de 20,1 % chez les 65 à 79 ans et chez les 80 ans ou plus, respectivement. Les amputations majeures étaient en baisse dans tous les groupes d’âge, alors qu’il y a eu une hausse de 26,2 % des amputations mineures chez les patients de 40 à 64 ans seulement. Le taux de mortalité à un an standardisé selon l’âge a diminué de 35,1 % (IC à 95 % : -43,4 à -25,7 %) entre 2006 et 2019, avec un taux de mortalité brut à un an de 11,3 % en 2019.

      Conclusions

      La réduction des amputations majeures d’un membre inférieur et de la mortalité à un an est encourageante, mais l’augmentation des amputations mineures d’un membre inférieur, surtout dans les groupes plus jeunes, souligne l’importance d’améliorer encore davantage les soins préventifs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels, Belgium: 2021 Available at: https://www.diabetesatlas.org. Accessed May 6, 2022.

        • Vouillarmet J.
        • Bourron O.
        • Gaudric J.
        • et al.
        Lower-extremity arterial revascularization: is there any evidence for diabetic foot ulcer-healing?.
        Diabetes Metab. 2016; 42: 4-15
        • Morley R.L.
        • Sharma A.
        • Horsch A.D.
        • Hinchliffe R.J.
        Peripheral artery disease.
        BMJ. 2018; 360: j5842
        • Abramson B.L.
        • Al-Omran M.
        • Anand S.
        • et al.
        Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease.
        Can J Cardiol. 2022; 38: 560-587
        • Embil J.M.
        • Albalawi Z.
        • Bowering K.
        • Trepman E.
        Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada : foot care.
        Can J Diabetes. 2018; 42: S222-S227
        • Imam B.
        • Miller W.C.
        • Finlayson H.C.
        • Eng J.J.
        • Jarus T.
        Incidence of lower limb amputation in Canada.
        Can J Public Health. 2017; 108: e374-e380
        • Hogg F.R.A.
        • Peach G.
        • Price P.
        • Thompson M.M.
        • Hinchliffe R.J.
        Measures of health-related quality of life in diabetes-related foot disease: a systematic review.
        Diabetologia. 2012; 55: 552-565
        • Thorud J.C.
        • Plemmons B.
        • Buckley C.J.
        • Shibuya N.
        • Jupiter D.C.
        Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review.
        J Foot Ankle Surg. 2016; 55: 591-599
        • Singh N.
        • Armstrong D.G.
        • Lipsky B.A.
        Preventing foot ulcers in patients with diabetes.
        JAMA. 2005; 293: 217-228
        • Hussain M.A.
        • Al-Omran M.
        • Salata K.
        • et al.
        Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease.
        Can Med Assoc J. 2019; 191: E955
        • Perkins B.A.
        Sounding the alarm on rising diabetes-related amputations.
        Can Med Assoc J. 2019; 191: E953
        • Brousseau-Foley M.
        • Blanchette V.
        multidisciplinary management of diabetic foot ulcers in primary cares in Québec: can we do better?.
        J Multidiscip Healthc. 2020; 13: 381-385
        • Dawes D.
        • Iqbal S.
        • Steinmetz O.K.
        • Mayo N.
        The evolution of amputation in the province of Québec.
        Can J Diabetes. 2010; 34: 58-66
        • Blais C.
        • Rochette L.
        • Ouellet S.
        • Huynh T.
        Complex evolution of epidemiology of vascular diseases, including increased disease burden: from 2000 to 2015.
        Can J Cardiol. 2020; 36: 740-746
        • LeBlanc A.G.
        • Jun Gao Y.
        • McRae L.
        • Pelletier C.
        At-a-glance: twenty years of diabetes surveillance using the Canadian Chronic Disease Surveillance System.
        Health Promot Chronic Dis Prev Can. 2019; 39: 306-309
        • Blais C.
        • Jean S.
        • Rochette L.
        • et al.
        Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach.
        Chronic Dis Inj Can. 2014; 34: 226-235
        • Schaper N.C.
        • van Netten J.J.
        • Apelqvist J.
        • et al.
        Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update).
        Diab Metab Res Rev. 2020; e3266
        • Hux J.E.
        • Ivis F.
        • Flintoft V.
        • Bica A.
        Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.
        Diabetes Care. 2022; 5: 512-516
      2. Ouhoummane N. Impact du diabète sur la mortalité à la suite d’une hospitalisation pour un premier infarctus aigu du myocarde au Québec. Doctorate thesis, Université Laval, 2010.

        • Ouhoummane N.
        • Abdous B.
        • Louchini R.
        • Rochette L.
        • Poirier P.
        Trends in postacute myocardial infarction management and mortality in patients with diabetes: a population-based study from 1995 to 2001.
        Can J Cardiol. 2010; 26: 523-531
        • Jacob-Brassard J.
        • Al-Omran M.
        • Stukel T.
        • et al.
        Validation of diagnosis and procedure codes for revascularization for peripheral artery disease in Ontario administrative databases.
        Clin Investig Med. 2021; 44: E36-E43
        • Simard M.
        • Sirois C.
        • Candas B.
        Validation of the combined comorbidity index of Charlson and Elixhauser to predict.
        Med Care. 2018; 56: 441-447
        • Syed M.H.
        • Al-Omran M.
        • Jacob-Brassard J.
        • et al.
        ICD-10 diagnostic coding for identifying hospitalizations related to a diabetic foot ulcer.
        Clin Investig Med. 2021; 44: E11-E16
        • Narres M.
        • Kvitkina T.
        • Claessen H.
        • et al.
        Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: a systematic review.
        PloS One. 2017; 12e0182081
        • Essien S.K.
        • Linassi A.G.
        • Farnan C.
        • Collins K.
        • Zucker-Levin A.
        The influence of primary and subsequent limb amputation on the overall rate of limb amputation in Saskatchewan, Canada, 2006-2019: a population-based study.
        BMC Surg. 2021; 21: 385
      3. Robert P, O’Connor S, Perron L, et al. Portrait du diabète dans la population québécoise âgée d’un an et plus de 2001 à 2019. Surveillance des maladies chroniques 2022;39:33p. Available at: https://www.inspq.qc.ca/sites/default/files/publications/2858-portrait-diabete-population-agee-un-plus.pdf. Accessed September 24, 2022.

        • Napolitano C.
        • Zmuda A.
        • Rottier F.J.
        • Pinzur M.S.
        • Stuck R.M.
        Amputations and rehabilitation.
        in: Veves A. Giurini J.M. Guzman R.J. The Diabetic Foot. 4th ed. Humana Press, Springer International Publishing, Totowa, NJ2018: 415-436
        • Jacob-Brassard J.
        • Al-Omran M.
        • Hussain M.A.
        • et al.
        Temporal trends in hospitalization for lower extremity peripheral artery disease in Ontario: the importance of diabetes.
        Can J Cardiol. 2021; 37: 1507-1512
        • Klaphake S.
        • de Leur K.
        • Mulder P.G.
        • et al.
        Mortality after major amputation in elderly patients with critical limb ischemia.
        Clin Interv Aging. 2017; 12: 1985-1992
        • Jacob-Brassard J.
        • Al-Omran M.
        • Stukel
        • et al.
        Trends in lower extremity revascularization and amputation for peripheral arterial disease over the last two decades: a population-based time series analysis.
        J Vasc Surg. 2021; 74: e245
        • Cascini S.
        • Agabiti N.
        • Davoli M.
        • et al.
        Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems.
        BMJ Open Diabetes Res Care. 2020; 8e001355
        • Kokkinidis D.G.
        • Arfaras-Melainis A.
        • Giannopoulos S.
        • et al.
        Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis.
        Vasc Med. 2020; 25: 106-117
        • Bonaca M.P.
        • Nault P.
        • Giugliano R.P.
        • et al.
        Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease.
        Circulation. 2018; 137: 338-350
        • Qamar A.
        • Morrow D.A.
        • Creager M.A.
        • et al.
        Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: analysis from the TRA 2°P-TIMI 50 trial.
        Vasc Med. 2020; 25: 124-132
        • Bauersachs R.M.
        • Szarek M.
        • Brodmann M.
        • et al.
        total ischemic event reduction with rivaroxaban after peripheral arterial revascularization in the VOYAGER PAD trial.
        J Am Coll Cardiol. 2021; 78: 317-326
        • Wounds Canada
        Quick Reference Guide: Quick Reference Guide Wound Prevention and Management: The Wound Prevention and Management Cycle.
        Canadian Association of Wound Care, 2017 (Available at:)
        • Dmytruk K.
        • O’Connell P.A.
        Diabetes foot care clinical pathway.
        Limb Preserv Can. 2021; 2: 26-28
        • Setterfield M.
        • Jowett E.
        Developing an Ontario strategy for lower-limb preservation.
        Limb Preserv Can. 2021; 2: 30-32
      4. The Council of the Federation. From innovation to action: the first report of the Health Care Innovation Working Group, 2012.

        • Botros M.
        • Gail Woodbury M.
        • Kuhnke J.
        • Despatis M.
        Saving diabetic limbs in Canada: partnership between the Public Health Agency of Canada and the Canadian Association of Wound Care.
        Int Wound J. 2012; 9: 231-233
        • New Perspectives in Diabetic Limb Preservation
        Building a Community of Practice.
        Limb Preservation in Canada: Symposium. 2019; 1: 12-15
        • Blanchette V.
        • Hains S.
        • Cloutier L.
        Establishing a multidisciplinary partnership integrating podiatric care into the Quebec public health-care system to improve diabetic foot outcomes: a retrospective cohort.
        Foot (Edinb). 2019; 38: 54-60
        • Fournier C.
        • Singbo N.
        • Morissette N.
        • Thibeault M.-M.
        Outcomes of diabetic foot ulcers in a tertiary referral interdisciplinary clinic: a retrospective Canadian study.
        Can J Diabetes. 2021; 45: 255-260
        • Anand S.S.
        • Bell A.D.
        • Szalay D.
        The time has come for vascular medicine in Canada.
        Can J Cardiol. 2021; 37: 1677
        • McClure G.R.
        • Kaplovitch E.
        • Chan N.
        • Anand S.S.
        Antithrombotic therapy in peripheral artery disease: risk stratification and clinical decision making.
        Can J Cardiol. 2022; 38: 654-661
        • McClure G.R.
        • Kaplovitch E.
        • Chan N.
        • et al.
        A national Canadian survey of antithrombotic therapy after urgent and emergent limb revascularization.
        Can J Cardiol. 2021; 37: 504-507
        • Mastracci T.M.
        • Anand S.S.
        • Aday A.W.
        Peripheral artery disease: a high-risk yet understudied, underdiagnosed, and undertreated condition: a call to action.
        Can J Cardiol. 2022; 38: 553-554
        • Rymer J.A.
        • Gutierrez J.A.
        Challenges in peripheral artery disease clinical trial implementation and design.
        Can J Cardiol. 2022; 38: 699-702

      Linked Article

      • Contrasting Trends in Vascular Amputations: Progress or Peril?
        Canadian Journal of CardiologyVol. 39Issue 3
        • Preview
          Amputation is a dreaded complication of peripheral artery disease (PAD) and diabetes mellitus. In this issue of the Canadian Journal of Cardiology, O’Connor et al. studied secular trends in the incidence of primary lower-extremity amputations (LEAs) associated with PAD or diabetes in the province of Québec, Canada, between the years 2006 and 2019.1 The investigators used large administrative databases linked together in the Quebec Integrated Chronic Disease Surveillance System to capture episodes of LEA, subclassifying these as major and minor, based on the highest level of amputation.
        • Full-Text
        • PDF